ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 116

Racial Differences in Self-Reported Pain and Disability: A Longitudinal Study of Knee Osteoarthritis

Ernest Vina1, Di Ran2, Erin Ashbeck2 and C. Kent Kwoh3, 1Rheumatology, University of Arizona, Tucson, AZ, 2University of Arizona, Tucson, AZ, 3Rheumatology, University of Arizona, College of Medicine, Tucson, AZ

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disability, longitudinal studies, Osteoarthritis, pain and race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Healthcare Disparities in Rheumatology - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:   Pain and disability from knee osteoarthritis (KOA) has been reported to be greater among African-Americans (AAs) than Whites (WHs), though progression in KOA-related symptoms by race has not been described. Our objective is to compare self-reported pain and disability between AAs and WHs, with or at high-risk of KOA, over 9 years of follow-up.

Methods:   The Osteoarthritis Initiative is a longitudinal cohort study of participants with or at risk of KOA, with up to 9 years of annual self-reported pain and disability assessments including WOMAC pain, pain severity in the past 30 days using a numerical rating scale (NRS), and WOMAC disability. Mixed models for repeated measures were used to estimate race group means and change in group means during follow-up, adjusted for age, sex, education, marital status, body mass index, and depression. Generalized linear mixed models for multinomial logistic regression were used to estimate the relative odds of reporting clinical improvement and worsening, based on established clinically important differences [CID], for AAs compared to WHs. The referent outcome was no CID, and 2 knees per participant were accounted for with random intercepts.

Results:   A total of 3790 WH and 874 AA subjects were included, with baseline mean WOMAC pain subscale scores of 1.9 (SD 2.8) and 4.4 (SD 4.4), respectively. During the first year follow-up, there was a significantly greater decline in mean WOMAC pain among AAs compared to WHs (-0.64 [95% CI: -0.78 to -0.50] vs. -0.15 [95% CI: -0.21 to -0.08]; p<0.0001), while mean pain levels remained stable between the 1 year and 9 year follow-up visits. Pain severity and WOMAC disability had similar patterns, with a significantly greater decline among AAs from baseline to first year follow-up, followed by relatively stable group means. However, AAs had significantly increased odds of reporting clinically important worsening and improvement in pain and disability among nearly all consecutive annual clinic visits, and across all three outcome measures, compared to WHs (Table 1).

Conclusion:   Race-specific group means suggest that AAs report a precipitous drop in KOA-related symptoms between first administration at baseline and second administration 1 year later, followed by stable average pain and disability. Closer examination revealed that AAs were more likely than WHs to report CID, both worsening and improvement, in KOA pain and disability, revealing substantial within-person variance among AAs. Whether the increased variability in responses from AAs reflects fluctuations in actual pain and disability experienced or lack of cross-cultural instrument validity is unknown. Self-reported measures of symptoms are accepted as primary endpoints in randomized controlled trials (RCTs). RCTs that rely on changes in these measures to demonstrate drug efficacy may suffer from obscured treatment effects among AAs.


Disclosure: E. Vina, None; D. Ran, None; E. Ashbeck, None; C. K. Kwoh, None.

To cite this abstract in AMA style:

Vina E, Ran D, Ashbeck E, Kwoh CK. Racial Differences in Self-Reported Pain and Disability: A Longitudinal Study of Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/racial-differences-in-self-reported-pain-and-disability-a-longitudinal-study-of-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/racial-differences-in-self-reported-pain-and-disability-a-longitudinal-study-of-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology